Article
The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys.
Vaccine - 15 Mar 2002
Skiadopoulos Mario H, Tatem Joanne M, Surman Sonja R, Mitcho Yvonne, Wu Shin Lu, Elkins William R, Murphy Brian R
Abstract excerpt
A recombinant live-attenuated chimeric human parainfluenza virus type 1 (HPIV1) candidate vaccine was previously generated by replacing the fusion (F) and hemagglutinin-neuraminidase (HN) glycoprotein open reading frames (ORFs) of the HPIV3 candidate vaccine, rHPIV3cp45, with those of wild-type HPIV1. Previously, this recombinant chimeric virus, designated rHPIV3-1cp45, exhibited a greater level of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
